A malaria vaccine developed by Oxford University and Serum Institute of India (SII) has been recommended for large-scale use by the World Health Organization (WHO). The R21/Matrix-M—only the second malaria jab—has shown up to 75% efficacy.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Mint Primer","authorlink":""},"src":"https:\/\/injector.simplecastaudio.com\/d92eabc3-c78d-44b4-98ff-f9eb200cb59a\/episodes\/1b31b757-effe-4af5-ac54-94a14ad26ef9\/audio\/128\/default.mp3?aid=rss_feed&awCollectionId=d92eabc3-c78d-44b4-98ff-f9eb200cb59a&awEpisodeId=1b31b757-effe-4af5-ac54-94a14ad26ef","thumb":{"src":"https:\/\/image.simplecastcdn.com\/images\/ae6533df-095e-4fef-b7ef-69ea44f76a8c\/b2d564be-3ff3-410d-8a4a-b471672ec439\/3000x3000\/mint-primer.jpg?aid=rss_feed&s=tellyfonic"},"title":"Malaria Gets its Second Vax: Why it\u2019s Momentous","link":"javascript:;","id":"item-123591058"}]
